Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Qiyue ShanZhou"'
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Aim to establish the inhibitors of programmed cell death protein 1 (PD-1) as second-line therapy for advanced esophageal squamous cell carcinoma (ESCC). Methods Published clinical trials in the PubMed, Medline, Embase databases on
Externí odkaz:
https://doaj.org/article/824d633b0da4415d9f2c220a391921ed
Autor:
Chunrong Zhu, Yunhe Li, Qiao Deng, Xinxin Liu, Qian Xia, Lei Zhong, Zhiyang Xia, Qiyue ShanZhou, Jun Lei, Jiang Zhu
Publikováno v:
Journal of Magnetic Resonance Imaging.
Autor:
Xin Chen, Can Luo, Yuting Bai, Lihua Yao, Qiyue Shanzhou, Yulei Xie, Shan Wang, Lei Xu, Xiaolan Guo, Xiaowu Zhong, Qing Wu
Publikováno v:
Critical reviews in eukaryotic gene expression. 32(7)
We investigated the regulatory effects of hypoxia-inducible factor-1a (HIF-1α) on glycolysis metabolism in esophageal carcinoma (ESCA) cells. A series of bioinformatics databases and tools were used to investigate the expression and role of HIF-1α
Publikováno v:
Oncology letters. 24(2)
Adenoid cystic carcinoma (ACC) is a type of malignant tumor arising from the salivary glands. The tumor is characterized by a predilection for recurrence and metastasis. At present, there is no effective treatment for ACC complicated with lung metast
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Background Aim to establish the inhibitors of programmed cell death protein 1 (PD-1) as second-line therapy for advanced esophageal squamous cell carcinoma (ESCC). Methods Published clinical trials in the PubMed, Medline, Embase databases on PD-1 inh